Search

In Stock

Buy Truxima (rituximab) Online

DISEASE INDICATIONS: Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis, Polyangiitis

MANUFACTURER: Celltrion Healthcare Hungary Kft / Teva Pharmaceuticals

USAGE: Intravenous

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Truxima (rituximab) is a drug employed in the management of various medical conditions, including follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL), chronic lymphocytic leukemia (CLL), severe active rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.

From $623.55

Clear
Compare

Truxima is a pharmaceutical medication that contains the active ingredient rituximab. It belongs to a class of medications known as monoclonal antibodies and is used for various medical conditions, primarily in the treatment of certain autoimmune diseases and types of cancer. Rituximab works by targeting and inhibiting the activity of specific cells in the immune system, which can help manage various conditions.

Here is a detailed description of Truxima:

Active Ingredient:

  • Rituximab: Rituximab is a monoclonal antibody that targets and binds to a protein called CD20 on the surface of certain immune cells, particularly B lymphocytes (B cells). By binding to CD20, rituximab helps to eliminate or reduce the activity of B cells, which are involved in various autoimmune diseases and cancers.

Indications:

Truxima is indicated for several medical conditions, including:

  1. Non-Hodgkin Lymphoma (NHL): Truxima is used in combination with chemotherapy to treat various forms of NHL, including follicular lymphoma, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia (CLL).
  2. Rheumatoid Arthritis (RA): Truxima is used in combination with methotrexate to manage moderate to severe rheumatoid arthritis in adult patients who have not responded well to other treatments.
  3. Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA): Truxima is used in combination with glucocorticoids to treat GPA and MPA, two rare autoimmune diseases that cause inflammation of small blood vessels.

Usage:

The dosing and administration of Truxima are determined by a healthcare provider and depend on the specific condition being treated. It is administered as an intravenous (IV) infusion, and the frequency and duration of treatment can vary.

Mechanism of Action:

Rituximab, the active ingredient in Truxima, works by targeting and binding to CD20 on B cells. This binding leads to the destruction or depletion of these B cells, which play a role in various autoimmune diseases and cancers. By reducing the activity of B cells, rituximab helps control the underlying disease processes.

Benefits:

The primary benefit of Truxima is its ability to target and inhibit B cells, which are involved in autoimmune diseases and certain types of cancer. By doing so, it can help manage these conditions, reduce symptoms, and improve the overall quality of life for patients.

Precautions:

Before starting Truxima, patients should undergo a thorough evaluation by a healthcare provider. It is important to inform the healthcare provider of any allergies, medical conditions, or other medications being taken, as these factors can affect the safety and efficacy of the medication.

Side Effects:

Common side effects of Truxima may include infusion reactions (fever, chills, rash, etc.), low blood cell counts, and an increased risk of infections. Patients may also experience mild to moderate reactions during the infusion, which can typically be managed by the healthcare provider. Serious side effects are possible but less common. Patients should promptly report any unusual or severe side effects to their healthcare provider.

In conclusion, Truxima (rituximab) is a medication used to treat various medical conditions, including certain autoimmune diseases and types of cancer. It works by targeting B cells in the immune system and is administered as an intravenous infusion. Patients should use it as directed by their healthcare provider and be aware of potential side effects and precautions associated with its use.

Package

1 vial of 100 mg, 1 vial of 500 mg

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Tremfya (guselkumab) Online

$2,860.64
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Janssen Biotech USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Pharmaceuticals and Medical Devices Agency (PMDA) Therapeutic Goods Administration (TGA) Tremfya is a pharmaceutical medication that contains the active ingredient guselkumab. It belongs to a class of medications known as interleukin-23 (IL-23) inhibitors and is primarily used in the treatment of certain chronic skin conditions, particularly moderate to severe plaque psoriasis. Guselkumab works by targeting specific proteins in the immune system that play a role in the development of psoriatic skin lesions, thereby reducing the symptoms associated with this condition.

Buy Rinvoq (upadacitinib) Online

$1,955.31
(0 Reviews)
Rinvoq is a pharmaceutical medication that contains the active ingredient upadacitinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Upadacitinib works by targeting specific enzymes in the immune system, helping to reduce inflammation and alleviate the symptoms associated with these conditions.

Buy Taltz (ixekizumab) Online

From $2,499.58
(0 Reviews)
DISEASE INDICATIONS: Psoriasis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Subcutaneous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.

Buy Olumiant (baricitinib) Online

From $1,070.33
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Eli Lilly Nederland B.V. USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Olumiant (baricitinib) is a prescription medication used to treat rheumatoid arthritis (RA), alopecia areata, and COVID-19. It is a Janus kinase (JAK) inhibitor, which means that it blocks the activity of JAK enzymes. JAK enzymes are involved in the signaling pathway that leads to inflammation.

Buy Tymlos (abaloparatide) Online

$2,636.72
(0 Reviews)
DISEASE INDICATIONS: Osteoporosis MANUFACTURER: Radius Health, Inc. USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA) Tymlos is a prescription medication used to treat osteoporosis, a condition characterized by the weakening of bones, which can lead to an increased risk of fractures and bone fractures. It is specifically indicated for postmenopausal women at high risk of fracture or those who have failed other osteoporosis treatments.

Buy Truxima (rituximab) Online

From $623.55
(0 Reviews)
DISEASE INDICATIONS: Leukemia, Lymphoma, Rheumatoid Arthritis, Granulomatosis, Polyangiitis MANUFACTURER: Celltrion Healthcare Hungary Kft / Teva Pharmaceuticals USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Health Canada Therapeutic Goods Administration (TGA) Medsafe (NZ) Truxima (rituximab) is a drug employed in the management of various medical conditions, including follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL), chronic lymphocytic leukemia (CLL), severe active rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.

Buy Jyseleca (filgotinib) Online

From $1,239.61
(0 Reviews)
DISEASE INDICATIONS: Rheumatoid Arthritis MANUFACTURER: Galapagos USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Pharmaceuticals and Medical Devices Agency (PMDA)   Jyseleca is a pharmaceutical medication that contains the active ingredient filgotinib. It belongs to a class of medications known as Janus kinase (JAK) inhibitors and is primarily used in the treatment of various autoimmune diseases, including rheumatoid arthritis. Filgotinib works by targeting specific enzymes involved in the inflammatory process, helping to reduce inflammation and manage the symptoms of these conditions.

Back to Top
Product has been added to your cart